How many insider trades does FilingIQ track for MDCX?

FilingIQ tracks 29 Form 4 insider transactions for MDCX (Medicus Pharma Ltd.), covering filings from May 20, 2025 onwards. 13 of those were filed in the last 90 days.

Are MDCX insiders net buyers or net sellers?

Across the full Form 4 history for MDCX, 0 transactions (0%) were open-market purchases and 1 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MDCX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MDCX in?

Medicus Pharma Ltd. (MDCX) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $12.21M.

MDCX insider trading

NasdaqCM Healthcare

Medicus Pharma Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 3%

Market cap

$12.21M

About Medicus Pharma Ltd.

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.

Company website: medicuspharma.com

MDCX insider activity at a glance

FilingIQ has scored 29 insider transactions for MDCX since May 20, 2025. The most recent filing in our index is dated Mar 30, 2026.

Across the full history, 0 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MDCX insider trades is 52.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MDCX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding MDCX

Interchange Capital Partners, LLC

$4.74M · 1.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for MDCX?: FilingIQ tracks 29 Form 4 insider transactions for MDCX (Medicus Pharma Ltd.), covering filings from May 20, 2025 onwards. 13 of those were filed in the last 90 days.
Are MDCX insiders net buyers or net sellers?: Across the full Form 4 history for MDCX, 0 transactions (0%) were open-market purchases and 1 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDCX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MDCX in?: Medicus Pharma Ltd. (MDCX) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $12.21M.

Methodology & sources

Every MDCX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.